Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610318 · ClinicalTrials.gov registry record · Early Phase 1
Feasibility and Acceptability of a Single Session of Imagery Rescripting in a Community Sample of Adults
A Early Phase 1 study, sponsored by University of Oregon.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 27
- Enrollment target
NCT06610318: Completed Early Phase 1 study, sponsored by University of Oregon.
NCT06610318 is a Early Phase 1 study that has completed, run by University of Oregon. The registered enrollment target is 27 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06610318, a Early Phase 1 study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
Negative experiences related to eating and appearance (NEREAs), such as critical commentary from parents about food, are common. They are also associated with depression and disordered eating, predictors of early mortality. Imagery rescripting (IR) is a therapeutic process during which individuals are guided through recalling distressing memories, like NEREAs, and generating ideas for bringing support into these memories. Single sessions of IR demonstrate promise in shifting the primary negative consequences of NEREAs in clinical samples of women. The current study examined the feasibility and acceptability of a remote-delivered, single session of IR in a community sample of men and women with NEREAs.
Primary Outcome
the total number of participants enrolled in the study and a demographic description of these participants, including their sex, gender, race, ethnicity, age and body mass index
Interventions
- BEHAVIORAL nutrition education
- BEHAVIORAL imagery rescripting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2024-06-01 |
| Phase | Early Phase 1 |
What the finished NCT06610318 record still lists
NCT06610318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 2 interventions - of which nutrition education is the first listed.
NCT06610318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06610318 about?
NCT06610318 is a clinical study titled "Feasibility and Acceptability of a Single Session of Imagery Rescripting in a Community Sample of Adults". Negative experiences related to eating and appearance (NEREAs), such as critical commentary from parents about food, are common. They are also associated with depression and disordered eating, predictors of early mortality. Imagery rescripting (IR) is a therapeutic process during which individuals a...
What is the current status of trial NCT06610318?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 27 participants. The study started on 2023-06-01. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT06610318?
The interventions under investigation include: nutrition education (BEHAVIORAL), imagery rescripting (BEHAVIORAL).
Who is sponsoring clinical trial NCT06610318?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06610318's enrollment target sits among peer trials
27 963rd of 2000 higher than 1,025 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI